These findings establish that aspirin and other NSAIDs activate the NF-κB pathway in neoplastic epithelial cells in the context of a whole tumour setting, and support the proposition that this effect is important for the anti-tumour activity of the agent. The gene discussed is NFKB1; the disease is neoplasm.